Novel tissue-derived brain organoids could revolutionize brain research

byPrincess Máxima Center for Pediatric OncologyAn image of a whole human fetal brain organoid. Stem cells are marked by SOX2 (grey) and neuronal cells (TUJ1) are color coded from pink to yellow

Updated on: January 09,2024

Novel tissue-derived brain organoids could revolutionize brain research

byPrincess Máxima Center for Pediatric OncologyAn image of a whole human fetal brain organoid. Stem cells are marked by SOX2 (grey) and neuronal cells (TUJ1) are color coded from pink to yellow

Updated on:January 09,2024

More exposure to artificial, bright, outdoor nighttime light linked to higher stroke risk

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainPeople continuously exposed to bright, artificial light at night may be at increased risk of developing conditions that affect blood

Updated on: March 28,2024

More exposure to artificial, bright, outdoor nighttime light linked to higher stroke risk

byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainPeople continuously exposed to bright, artificial light at night may be at increased risk of developing conditions that affect blood

Updated on:March 28,2024

Exercise offers protection against Alzheimer's

by Massachusetts General HospitalCredit: CC0 Public DomainHigher levels of daily physical activity may protect against the cognitive decline and neurodegeneration (brain tissue loss) from Alzheim

Updated on: May 26,2024

Exercise offers protection against Alzheimer's

by Massachusetts General HospitalCredit: CC0 Public DomainHigher levels of daily physical activity may protect against the cognitive decline and neurodegeneration (brain tissue loss) from Alzheim

Updated on:May 26,2024

Cellular architecture of lesions in multiple sclerosis now mapped out

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainUsing advanced methodology, scientists in Sweden were able to reveal at the cellular level how lesions in multiple sclerosis develop. The

Updated on: March 27,2024

Cellular architecture of lesions in multiple sclerosis now mapped out

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainUsing advanced methodology, scientists in Sweden were able to reveal at the cellular level how lesions in multiple sclerosis develop. The

Updated on:March 27,2024

Hidden belly fat in midlife linked to Alzheimer's disease

by Radiological Society of North AmericaIncreased neuroinflammation (yellow colors) associated with higher hidden fat (visceral fat) in the cohort of 54 participants with an average age of 50 yea

Updated on: February 24,2024

Hidden belly fat in midlife linked to Alzheimer's disease

by Radiological Society of North AmericaIncreased neuroinflammation (yellow colors) associated with higher hidden fat (visceral fat) in the cohort of 54 participants with an average age of 50 yea

Updated on:February 24,2024

An alternate theory for what causes Alzheimer's disease

by University of California - RiversideTyler Lambeth (left) and Ryan Julian in the lab. Credit: Julian lab, UC RiversideAlzheimer's disease, the most common cause of dementia among the elderl

Updated on: April 18,2024

An alternate theory for what causes Alzheimer's disease

by University of California - RiversideTyler Lambeth (left) and Ryan Julian in the lab. Credit: Julian lab, UC RiversideAlzheimer's disease, the most common cause of dementia among the elderl

Updated on:April 18,2024

Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'

by Steven Slivka, John Domol,University of Nevada, Las VegasDr. Jeffrey Cummings, research professor and director, Chambers-Grundy Center for Transformative Neuroscience at UNLV. Credit: Josh Ha

Updated on: April 28,2024

Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'

by Steven Slivka, John Domol,University of Nevada, Las VegasDr. Jeffrey Cummings, research professor and director, Chambers-Grundy Center for Transformative Neuroscience at UNLV. Credit: Josh Ha

Updated on:April 28,2024

Higher light levels may improve cognitive performance

by Emily Packer,eLifeExperimental protocol. (A) Overall timeline. After prior light history standardization, participants performed executive (always first), emotional and attentional tasks (pse

Updated on: April 28,2024

Higher light levels may improve cognitive performance

by Emily Packer,eLifeExperimental protocol. (A) Overall timeline. After prior light history standardization, participants performed executive (always first), emotional and attentional tasks (pse

Updated on:April 28,2024

Single-cell RNA sequencing reveals heterogeneity in fibrotic scars after spinal cord injury

byChinese Academy of SciencesSchematic diagram of fibrotic scar heterogeneity after spinal cord injury. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50564-xMyofibrobla

Updated on: September 03,2024

Single-cell RNA sequencing reveals heterogeneity in fibrotic scars after spinal cord injury

byChinese Academy of SciencesSchematic diagram of fibrotic scar heterogeneity after spinal cord injury. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50564-xMyofibrobla

Updated on:September 03,2024

How the brain can miraculously switch off pain

Updated on: March 09,2025

How the brain can miraculously switch off pain

Updated on:March 09,2025

New gene therapy for muscular dystrophy offers hope

byUniversity of Washington School of MedicineA schematic illustration of a multi-shuttle system to deliver full dystrophin protein to muscle cells body-wide as a genetic therapy for muscular dys

Updated on: July 25,2024

New gene therapy for muscular dystrophy offers hope

byUniversity of Washington School of MedicineA schematic illustration of a multi-shuttle system to deliver full dystrophin protein to muscle cells body-wide as a genetic therapy for muscular dys

Updated on:July 25,2024

Study finds frexalimab has favorable effect on relapsing multiple sclerosis

FEBRUARY 15, 2024by Elana GotkineFor patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weigh

Updated on: March 28,2024

Study finds frexalimab has favorable effect on relapsing multiple sclerosis

FEBRUARY 15, 2024by Elana GotkineFor patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weigh

Updated on:March 28,2024